⌕
Omnicell · OMCL · Nasdaq
Tenet 51 · Mixed
Compare
$34.00−4.06%At closeTenet 51 · Mixed
$34.00−1.44 (−4.06%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Omnicell (OMCL) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~1.1%/yr (FY21→FY25), net margin 0.2%, and free cash flow (~$86.9M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($M)▲6.5%
1,184.8
FY21→FY25CAGR +1.1%/yr
Net income ($M)▼83.6%
2.1
one-off year: see footnoteCAGR −59.7%/yr
Free cash flow ($M)▼42.6%
86.9
FY21→FY25CAGR −19.1%/yr
Diluted EPS▼85.2%
0.04
buyback-liftedCAGR −60.4%/yr
What the receipts whisper · what a headline number hides
Share count
−3.3%

47.9mn → 46.4mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$40.4M

steady at 3.4% of revenue (+10.8% YoY).

Returns vs FCF
89%

$77.6M returned vs $86.9M of FCF in FY25. Buybacks covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)1184.8Revenue−681.4COGS503.4Gross profit−88.7R&D−409.6SG&A5.2Op income−3.1Tax & other2.1Net income

0¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
503825130%sector median net margin ~3%FY21FY25

Over this window: gross 49.0% → 42.5%. Net margin 0.2% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
1,243,923.01,184,845.01,112,238.01,147,112.01,295,947.01,132,018.0▲6.5%+1.1%
Cost of revenue
682,474.0681,403.0641,235.0650,272.0706,960.0577,365.0▲6.3%+4.2%
Gross profit
561,449.0503,442.0471,003.0496,840.0588,987.0554,653.0▲6.9%−2.4%
Research & development
86,722.088,672.090,412.097,115.0104,969.075,716.0▼1.9%+4.0%
Selling, general & admin
410,076.0409,610.0380,254.0434,593.0486,341.0389,430.0▲7.7%+1.3%
Total operating expenses
496,798.0498,282.0470,666.0531,708.0591,310.0465,146.0▲5.9%+1.7%
Operating incomefeeds ROC rank
64,651.05,160.0337.0−34,868.0−2,323.089,507.0▲1431.2%−51.0%
Other income, net
2,590.06,165.025,256.014,760.0−130.0−23,500.0——
Pretax income
67,241.011,325.025,593.0−20,108.0−2,453.066,007.0▼55.7%−35.6%
Income tax
22,576.09,273.013,062.0263.0−8,101.0−11,842.0▼29.0%—
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
44,665.02,052.012,531.0−20,371.05,648.077,849.0▼83.6%−59.7%
Per share
Diluted EPSbuyback-sensitive
0.960.040.27−0.450.121.62▼85.2%−60.4%
Diluted shares (mn)
46.4746.3646.2645.2145.8947.94▲0.2%−0.8%
Margins
Gross margin25th pct in Healthcare
45.1%42.5%42.3%43.3%45.4%49.0%▲0.1pp−6.5pp
Operating margin
5.2%0.4%0.0%−3.0%−0.2%7.9%▲0.4pp−7.5pp
Net margin52nd pct in Healthcare
3.6%0.2%1.1%−1.8%0.4%6.9%▼1.0pp−6.7pp
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was −18% vs a 51% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was 330% vs a 51% norm for this window, likely a one-time item; see the filing.
FY09 – FY20 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Omnicell's revenue last fiscal year?

Omnicell reported revenue of $1,184.8M in fiscal 2025, up 6.5% from fiscal 2024.

What was Omnicell's net income?

Omnicell reported net income of $2.1M in fiscal 2025, a net margin of 0.2%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.